Agenda & Learning Objectives

Participants in this program will:

  • Review the current status of the GEM Project
  • Explore current and future IBD therapies and mechanisms of action
  • Consider current and future diagnostic and therapeutic applications for genetics in IBD
  • Integrate basic science and clinical practice by participating in a choice of workshops to:
    • Review the current findings of the IMAGINE study
    • Develop an understanding of current and novel complementary medicines in IBD
    • Consider the latest research in nutrition and IBD
    • Examine technology for diagnostic and therapeutic applications in IBD
  • Examine the evolving role of complementary medicine in the treatment of IBD

NOTE: Junior Investigator Award – Please go to the Call for Abstracts page on the registration site

Time Title/Topic Speakers
08:30

0.1 Welcome 
Nurse of the Year Award, Physician of the Year Award, CCC-Pfizer Women in IBD Emerging Researcher Award, CCC-Pfizer Women in IBD Outstanding Researcher Award

 Lori Radke
CEO, Crohn's and Colitis Canada
08:50 0.2 Opening Remarks – Welcome, program objectives 
CO-CHAIRS:
Remo Panaccione & Hillary Steinhart
09:00 0.3 Overview of the GEM Project (15 mins)

Kenneth Croitoru

Session I: New Therapies in Combination
SESSION CHAIR:
Laura Targownik
09:15

1.1 Plenary Presentation
Emerging Therapies: What, where, why and when

 Brian Feagan
09:35

1.2 Plenary Presentation
Mechanisms: New Therapies

 Stefan Schreiber
09:55

1.3 Ask-the Expert Panel Session

 MODERATOR: Laura Targownik
PANEL: Brian Feagan, Vivian Huang, Stefan Schreiber
10:15

1.4 Junior Investigator Award & Presentation

 TBA
10:35 Refreshment Break (15 minutes)  

Session II: Genetics in IBD

 SESSION CHAIR: Heather Armstrong
10:50

2.1 Plenary Presentation
Genetics in IBD: Where are we now?

 Mark Silverberg
11:10

2.2 Plenary Presentation
Beyond Genetics: What is next?

 John Rioux
11:30 2.3 Ask-the Expert Panel Session MODERATOR: Heather Armstrong
PANEL: Sally Lawrence, John Rioux, Mark Silverberg
11:50 2.4 Rising Star Award & Presentation (title TBA) TBA
12:10 Lunch Break (60 minutes)  

Session III: Workshops – Hot Topics from Bench to Policy
13:10 Placement into Workshops  
13:15

3.1 Workshop
IMAGINE Study Update

 Deborah Marshall & Paul Moayyedi

3.2 Workshop
Evidence and Positioning of Complementary Medicines in IBD

 Dawn Beaulieu & Nir Solomon

3.3 Workshop
Nutrition and IBD

 Genelle Lunken & Eytan Wine

3.4 Workshop
Technology: AI and IBD

 Michael Byrne & Kerri Novak
14:00 Grab and Go Break (5 minutes)  

Session IV: Revisiting Complementary Approaches in IBD

 SESSION CHAIR:
ELena Verdu
14:05 4.0 Research Leadership Award & Presentation TBA
14:25

4.1 Plenary Presentation
Nutraceuticals in IBD: Bedside to Bench

 Nir Solomon
14:45

4.2 Plenary Presentation
Nutrition in IBD: Bedside to Bench

 Eytan Wine
15:05 4.3 Ask-the Expert Panel Session MODERATOR: Elena Verdu
PANEL: Maitreyi Raman, Nir Solomon, Eytan Wine
15:25 Closing Remarks and Program Evaluation CO-CHAIRS: 
Remo Panaccione & Hillary Steinhart

  • Canada has among the highest incidence rates of Crohn's and colitis in the world.
  • 1 in 140 Canadians lives with Crohn’s or colitis.
  • Families new to Canada are developing these diseases for the first time.
  • Incidence of Crohn’s in Canadian kids under 10 has doubled since 1995.
  • People are most commonly diagnosed before age 30.